Nektar Therapeutics
NKTR
#5957
Rank
NZ$1.73 B
Marketcap
NZ$85.17
Share price
-7.77%
Change (1 day)
228.89%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): NZ-$13.62

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$13.81. In 2024 the company made an earnings per share (EPS) of NZ-$15.35 an increase over its 2023 EPS that were of NZ-$37.94.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$13.62-11.28%
2024NZ-$15.35-59.54%
2023NZ-$37.94-25.89%
2022NZ-$51.20-31.12%
2021NZ-$74.3314.86%
2020NZ-$64.71-1.19%
2019NZ-$65.49-163.96%
2018NZ$102.40-725.4%
2017NZ-$16.37-42.73%
2016NZ-$28.5983.33%
2015NZ-$15.5939.53%
2014NZ-$11.18-69.29%
2013NZ-$36.38-6.67%
2012NZ-$38.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
NZ$22.58-263.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.98-121.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.16-195.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
NZ$0.01733-100.13%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$5.26-138.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
NZ-$1.14-91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ$3.59-125.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
NZ$18.09-230.98%๐Ÿ‡บ๐Ÿ‡ธ USA